Geneva:
The World Health Organization mentioned on Wednesday it had received information from Pfizer and BioNTech on the COVID-19 vaccine and was reviewing it for “possible listing for emergency use”, a benchmark for nations to authorise national use.
Referring to Britain’s regulator, the Medicines and Healthcare merchandise Regulatory Agency, it mentioned in a statement to Reuters: “WHO is also in discussions with MHRA on the possibility of accessing some of the information from their assessment, which could expedite WHO’s emergency listing”.
Britain authorized Pfizer’s COVID-19 vaccine on Wednesday, jumping ahead of the United States and Europe to develop into the West’s initially nation to formally endorse a shot it mentioned need to attain the most vulnerable persons early subsequent week.
Mike Ryan, WHO’s major emergency specialist, welcomed the news, adding: “We shouldn’t stop, we need more than 3-4 vaccines “We require to enhance production, we require to pull the cost down,” he told a social media occasion.
(This story has not been edited by The Spuzz employees and is auto-generated from a syndicated feed.)